Two new IPOs -- up­sized and over the range -- score $226M and sig­nal a pos­si­ble come­back for biotech

There are two new biotech IPOs out and trad­ing this morn­ing, and both are of­fer­ing some pre­lim­i­nary signs that the biotech win­dow is open­ing up …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.